First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- PMID: 26466011
- DOI: 10.1056/NEJMx150034
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Erratum for
-
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.N Engl J Med. 2014 Dec 4;371(23):2167-77. doi: 10.1056/NEJMoa1408440. N Engl J Med. 2014. PMID: 25470694 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources